World Swine Vaccine Market Driven by PCV2 Vaccination

The global swine industry increasingly relies on vaccination, according to Boehringer Ingelheim. With a total market value of €525 million in 2008, vaccines have become the most important health management tool for modern pig production (Vetnosis Ltd, March 2009).

The driver of this growth are vaccines against Porcine Circovirus Type 2 (PCV2), which have quickly become a standard vaccination in all major markets, alongside Mycoplasma vaccination programmes. The size of the PCV2-vaccine market is close to €180 million.

With total sales of ”€90 million, Boehringer's Ingelvac CircoFLEX was the global market leader in this segment last year (Animal Pharm, April 2009 and Boehringer Ingelheim).

Sign up for our
regular news updates

Related news items:

•    Biosecurity Benchmarking Study to Be Launched
•    Tyson Foods Names New Top Executives
•    OIE Reports New ASF Outbreak in Russia
•    Commission to Tackle Anti-Microbial Resistance
•    VIV China Reflects Development of Chinese Industry

Related News Categories: Pig Health, Company/Products

Sign up for our
regular news updates

More of the latest Pig Industry News

•   Lack of Number Continue to Hold Up Cull Sow Prices
•   Interest in US Feed Grains Grows in Viet Nam
•   Biosecurity Benchmarking Study to Be Launched
•   Tyson Foods Names New Top Executives
•   WTO Investigates Poultry, Livestock Complaints
•   OIE Reports New ASF Outbreak in Russia
•   UK Slaughter Statistics - November 2009
•   CME: Drop in Pork Prices Seen in October
•   Taiwanese Nutritionists Learn About DDGS
•   Commission to Tackle Anti-Microbial Resistance